Tattoo-Limited Granulomatous Reactions During BRAF/MEK Inhibition in Metastatic Melanoma: Further Clinical Experience from Two Additional Cases
Background/Objectives: Tattoo-associated inflammatory reactions during BRAF/MEK inhibitor therapy are uncommon and remain poorly characterized. Building on the case previously reported by Baratta et al., we describe two additional patients with melanoma who developed granulomatous reactions confined to pre-existing tattoos during combined BRAF/MEK inhibition. Case Presentation: Both patients were young men with advanced melanoma and developed well-demarcated eczematous and infiltrated plaques restricted to black tattooed skin. Histological examination showed non-necrotizing granulomatous dermatitis with pigment-containing histiocytes and multinucleated giant cells, consistent with a foreign-body-type reaction. In one patient the reaction remained limited to the skin, whereas the other developed systemic symptoms together with persistent laboratory abnormalities. In both scenarios 18F-FDG PET/CT also showed focal hypermetabolic activity corresponding to the tattooed areas. Conclusions: These observations add to the limited clinical experience with tattoo-restricted granulomatous reactions during BRAF/MEK inhibition. They also underline the broader immunomodulatory effects of targeted therapy and the need to recognize this uncommon adverse event in order to avoid misinterpretation and potentially unnecessary treatment changes. Further reports are needed to better define its pathogenesis and possible association with systemic toxicity or treatment response.
Authors
- Giuseppe Rizzuto (ORCID: https://orcid.org/0009-0001-4367-0341)
- Luca Filippi (ORCID: https://orcid.org/0000-0003-4423-5496)
- Claudio Di Cristofano (ORCID: https://orcid.org/0000-0003-2891-5598)
- Concetta Potenza (ORCID: https://orcid.org/0000-0002-6300-8697)
- Ilaria Proietti (ORCID: https://orcid.org/0000-0003-3795-3190)
- Alberto Taliano (ORCID: https://orcid.org/0009-0002-0811-7601)
- Steven Paul Nisticò (ORCID: https://orcid.org/0000-0002-3828-0883)
- Luca Guarino (ORCID: https://orcid.org/0009-0002-9678-6409)
- Vincenzo Coppolelli (ORCID: https://orcid.org/0009-0001-8346-8359)
- Lako Kostika
Institutions
- University of Rome Tor Vergata (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/jcm15228963
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00